CIK 0001723128
- Large accelerated filer
Amneal Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +1 908-947-3120
- Former names
- Atlas Holdings, Inc.
- 4 Open-market sale 10% owner sold 5,000,000 shares at $8.35 ($41,750,000)
- 4 Gift Director gave 262,072 shares (gift)
- 4 Open-market sale Executive Vice President sold 125,000 shares at $8.89 ($1,111,250)
- 4 Open-market sale EVP, Chief Legal Officer sold 90,000 shares at an average $8.80 ($792,160)
- 4 Open-market sale Executive Vice President & CFO sold 100,000 shares at $8.91 ($891,000)
- 4 Open-market sale Director sold 80,000 shares at $8.90 ($712,000)
- 4 Shares withheld for taxes EVP, Chief Legal Officer gave up 64,724 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 145,342 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President & CFO gave up 155,907 shares (to pay taxes)
- 4 Shares withheld for taxes President & Co-CEO gave up 326,888 shares (to pay taxes)
- 4 Shares withheld for taxes Co-CEO gave up 320,835 shares (to pay taxes)
- 4 Open-market sale Director sold 80,000 shares at $8.90 ($712,000)
- 4 Shares withheld for taxes Executive Vice President gave up 134,481 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 11,737 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President & CFO gave up 13,494 shares (to pay taxes)
- 4 Shares withheld for taxes Executive Vice President gave up 10,985 shares (to pay taxes)
- 4 Open-market sale Director sold 80,000 shares at $8.14 ($651,200)
- 4 Planned sale Director sold 62,590 shares at $8.01 ($501,346)
- 4 Planned sale Director sold 17,410 shares at $8.01 ($139,454)
- 4 Open-market sale Director sold 17,058 shares at $8.38 ($142,946)
Page 4 of 18 · 351 filings